121 related articles for article (PubMed ID: 38097153)
1. Smyd1: Implications for novel approaches in rhabdomyosarcoma therapy.
Berkholz J; Schmitt A; Fragasso A; Schmid AC; Munz B
Exp Cell Res; 2024 Jan; 434(2):113863. PubMed ID: 38097153
[TBL] [Abstract][Full Text] [Related]
2. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
3. The E3 SUMO ligase Nse2 regulates sumoylation and nuclear-to-cytoplasmic translocation of skNAC-Smyd1 in myogenesis.
Berkholz J; Michalick L; Munz B
J Cell Sci; 2014 Sep; 127(Pt 17):3794-804. PubMed ID: 25002400
[TBL] [Abstract][Full Text] [Related]
4. Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation.
Zhu L; Brown MA; Sims RJ; Tiwari GR; Nie H; Mayfield RD; Tucker HO
Cells; 2023 Jun; 12(13):. PubMed ID: 37443729
[TBL] [Abstract][Full Text] [Related]
5. skNAC and Smyd1 in transcriptional control.
Berkholz J; Orgeur M; Stricker S; Munz B
Exp Cell Res; 2015 Aug; 336(2):182-91. PubMed ID: 26162853
[TBL] [Abstract][Full Text] [Related]
6. skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration.
Park CY; Pierce SA; von Drehle M; Ivey KN; Morgan JA; Blau HM; Srivastava D
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20750-5. PubMed ID: 21071677
[TBL] [Abstract][Full Text] [Related]
7. Defective myogenesis in the absence of the muscle-specific lysine methyltransferase SMYD1.
Nagandla H; Lopez S; Yu W; Rasmussen TL; Tucker HO; Schwartz RJ; Stewart MD
Dev Biol; 2016 Feb; 410(1):86-97. PubMed ID: 26688546
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the skNAC gene in human rhabdomyosarcoma cells enhances their differentiation potential and inhibits tumor cell growth and spreading.
Berkholz J; Kuzyniak W; Hoepfner M; Munz B
Clin Exp Metastasis; 2014 Dec; 31(8):869-79. PubMed ID: 25209525
[TBL] [Abstract][Full Text] [Related]
9. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.
Walters ZS; Villarejo-Balcells B; Olmos D; Buist TW; Missiaglia E; Allen R; Al-Lazikani B; Garrett MD; Blagg J; Shipley J
Oncogene; 2014 Feb; 33(9):1148-57. PubMed ID: 23435416
[TBL] [Abstract][Full Text] [Related]
10. siRNA-mediated inhibition of skNAC and Smyd1 expression disrupts myofibril organization: Immunofluorescence and electron microscopy study in C2C12 cells.
Berkholz J; Eberle R; Boller K; Munz B
Micron; 2018 May; 108():6-10. PubMed ID: 29499397
[TBL] [Abstract][Full Text] [Related]
11. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.
Taulli R; Foglizzo V; Morena D; Coda DM; Ala U; Bersani F; Maestro N; Ponzetto C
Oncogene; 2014 May; 33(18):2354-62. PubMed ID: 23728344
[TBL] [Abstract][Full Text] [Related]
12. SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin.
Li D; Niu Z; Yu W; Qian Y; Wang Q; Li Q; Yi Z; Luo J; Wu X; Wang Y; Schwartz RJ; Liu M
Nucleic Acids Res; 2009 Nov; 37(21):7059-71. PubMed ID: 19783823
[TBL] [Abstract][Full Text] [Related]
13. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
Zhang M; Zhu B; Davie J
J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
[TBL] [Abstract][Full Text] [Related]
15. Stability of Smyd1 in endothelial cells is controlled by PML-dependent SUMOylation upon cytokine stimulation.
Becker S; Steinemann G; Karle W; Roos K; Liem CH; Muralikumar S; Volkamer A; Munz B; Zakrzewicz A; Berkholz J
Biochem J; 2021 Jan; 478(1):217-234. PubMed ID: 33241844
[TBL] [Abstract][Full Text] [Related]
16. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.
Tombolan L; Poli E; Martini P; Zin A; Millino C; Pacchioni B; Celegato B; Bisogno G; Romualdi C; Rosolen A; Lanfranchi G
BMC Cancer; 2016 Nov; 16(1):886. PubMed ID: 27842508
[TBL] [Abstract][Full Text] [Related]
17. TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma.
Shah AM; Guo L; Morales MG; Jaichander P; Chen K; Huang H; Cano Hernandez K; Xu L; Bassel-Duby R; Olson EN; Liu N
Sci Adv; 2023 Apr; 9(17):eade8184. PubMed ID: 37115930
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo.
Raimondi L; Ciarapica R; De Salvo M; Verginelli F; Gueguen M; Martini C; De Sio L; Cortese G; Locatelli M; Dang TP; Carlesso N; Miele L; Stifani S; Limon I; Locatelli F; Rota R
Cell Death Differ; 2012 May; 19(5):871-81. PubMed ID: 22117196
[TBL] [Abstract][Full Text] [Related]
19. Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray.
Stewart MD; Lopez S; Nagandla H; Soibam B; Benham A; Nguyen J; Valenzuela N; Wu HJ; Burns AR; Rasmussen TL; Tucker HO; Schwartz RJ
Dis Model Mech; 2016 Mar; 9(3):347-59. PubMed ID: 26935107
[TBL] [Abstract][Full Text] [Related]
20. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.
Zhang M; Truscott J; Davie J
Mol Cancer; 2013 Nov; 12(1):150. PubMed ID: 24279793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
